Oxidative stress and airway inflammation in severe exacerbations of COPD

Thorax

Volumn 60, Issue 4, 2005, Pages 293-300

  Drost, E M ^a,b   Skwarski, K M ^c   Sauleda, J ^d   Soler, N ^e   Roca, J ^e   Agusti, A ^d   MacNee, W ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^d HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^e UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AIRWAY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; LEUKOCYTE; LUNG BIOPSY; LUNG LAVAGE; MALE; NUCLEAR LOCALIZATION SIGNAL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DNA BINDING; RESPIRATORY TRACT INFLAMMATION; SMOKING; SPUTUM; BRONCHITIS; CHEMISTRY; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

BRONCHITIS; BRONCHOALVEOLAR LAVAGE FLUID; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-8; MALE; MIDDLE AGED; NF-KAPPA B; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 16844364420     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2004.027946     Document Type: Article

References (47)

1. Keatings VM, Barnes PJ. Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. Am J Respir Crit Care Mod 1997;155:449-53.
2. Bhowmik A, Seemungal TA, Sapsford RJ, et al. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 2000;55:114-20.
3. Paredi P, Kharitonov SA, Leak D, et al. Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;162:369-73.
4. Morrison D, Rahman I, Lannan S, et al. Epithelial permeability, inflammation, and oxidant stress in air spaces of smokers. Am J Respir Crit Care Med 1999;159:473-9.
5. Rahman I, Morrison D, Donaldson K, et al. Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med 1996;154:1055-60.
6. Pesci A, Balbi B, Majori M, et al. Inflammatory cells and mediators in bronchial lavage of patients with chronic pulmonary disease. Eur Respir J 1998;12:380-6.
7. Rahman I, MacNee W. Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. Free Radic Biol Med 2000;28:1405-20.
8. Drost EM, Ritchie HE, Skwarska E, et al. NF-κB activation in airway leucocytes in COPD patients. Eur Respir J 2001;16:260s.
9. MacNee W, Wiggs B, Belzberg AS, et al. The effect of cigarette smoking on neutrophil kinetics in human lungs. N Engl J Med 1989;321:924-8.
10. Selby C, Drost E, Lannan S, et al. Neutrophil retention in the lungs of patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1991;143:1359-64.
11. Drost EM, Selby C, Bridgeman MM, et al. Decreased leukocyte deformability after acute cigarette smoking in humans. Am Rev Respir Dis 1993;148:1277-83.
12. Li XY, Rahman I, Donaldson K, et al. An investigation of the mechanism of the increased epithelial permeability induced by cigarette smoking in vivo and in vitro models. Am J Respir Crit Care Med 1994;149:1518-25.
13. Rahman I, Li XY, Donaldson K, et al. Glutathione homeostasis in alveolar epithelial cells in vitro and lung in vivo under oxidative stress. Am J Physiol 1995;269:L285-92.
14. Cantin AM, North SL, Hubbard RC, et al. Normal alveolar epithelial lining fluid contains high levels of glutathione. J Appl Physiol 1987;63:152-7.
15. Rahman I, Smith CA, Lawson MF, et al. Induction of gamma-glutamylcysteine synthetase by cigarette smoke is associated with AP-1 in human alveolar epithelial cells. FEBS Lett 1996;396:21-5.
16. Donaldson GC, Seemungal TA, Patel IS, et al. Longitudinal changes in the nature, severity and frequency of COPD exacerbations. Eur Respir J 2003;22:931-6.
17. Pauwels RA, Buist AS, Calverley PMA, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care Med 2001;163:1256-76.
18. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-46.
19. Kelly CA, Kotre CJ, Ward C, et al. Anatomical distribution of bronchoalveolar lavage fluid as assessed by digital subtraction radiography. Thorax 1987;42:624-8.
20. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidised glutathione: applications to mammalian blood and other tissues. Anal Biochem 1969;27:502-22.
21. Vandeputte C, Guizon I, Genestie-Denis I, et al. A microtiter plate assay for total glutathione and glutathione disulfide contents in cultured/isolated cells: performance study of a new miniaturized protocol. Cell Biol Toxicol 1994;10:415-21.
22. Andrews NC, Faller DV. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucl Acids Res 1991;19:2499.
23. Gilmour PS, Brown DM, Beswick PH, et al. Free radical activity of industrial fibres: role of iron in oxidative stress and activation of transcription factors. Environ Health Perspect 1997;105(Suppl 5):1313-7.
24. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350:2645-53.
25. Di Stefano A, Capelli A, Lusuardi M, et al. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med 1998;158:1277-85.
26. Aaron SD, Angel JB, Lunau M, et al. Granulocyte inflammatory markers and airway infection during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:349-55.
27. Linden M, Rasmussen JB, Piitulainen E, et al. Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitis. Am Rev Respir Dis 1993;148:1226-32.
28. Peleman RA, Rytila PH, Kips JC, et al. The cellular composition of induced sputum in chronic obstructive pulmonary disease. Eur Respir J 1999;13:839-43.
29. Yildiz F, Kaur AC, Ilgazli A, et al. Inhaled corticosteroids may reduce neutrophilic inflammation in patients with stable chronic obstructive pulmonary disease. Respiration 2000;67:71-6.
30. Keatings VM, Collins PD, Scott DM, et al. Differences in interleukin-8 and tumour necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med 1996;153:530-4.
31. Tanino M, Betsuyaku T, Takeyabu K, et al. Increased levels of interleukin-8 in BAL fluid from smokers susceptible to pulmonary emphysema. Thorax 2002;57:405-11.
32. Qiu Y, Zhu J, Bandi V, et al. Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;168:968-75.
33. Saetta M, Stefano AD, Turato G, et al. Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med 1994;150:1646-52.
34. Nocker RET, Schoonbrood DFM, van de Graaf EA, et al. Interleukin-8 in airway inflammation in patients with asthma and chronic obstructive pulmonary disease. Int Arch Allergy Immunol 1996;109:183-91.
35. Richman-Eisenstat JBY, Jorens PG, Herbert CA, et al. Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. Am J Physiol: Lung Cell Mol Physiol 1993;264:L413-8.
36. Yamamoto C, Yoneda T, Yoshikawa M, et al. Airway inflammation in COPD assessed by sputum levels of interleukin-8. Chest 1997;112:505-10.
37. Woolhouse IS, Bayley DL, Stockley RA. Effect of sputum processing with dithiothreitol on the detection of inflammatory mediators in chronic bronchitis and bronchiectasis. Thorax 2002;57:667-71.
38. Soler N, Ewig S, Torres A, et al. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J 1999;14:1015-22.
39. Roebuck KA Regulation of interleukin-8 gene expression. J Interferon Cytokine Res 1999;19:429-38.
40. Vayssier M, Favatier F, Pinot F, et al. Tobacco smoke induces coordinate activation of HSF and inhibition of NFkappaB in human monocytes: effects on TNFα release. Biochem Biophys Res Commun 1998;252:249-56.
41. Favatier F, Polla BS. Tobacco smoke-inducible human haem oxygenase-1 gene expression: role of distinct transcription factors and reactive oxygen intermediates. Biochem J 2001;35:475-82.
42. Nishikawa, M, Kakemizu N, Ito T, et al. Superoxide mediates cigarette smoke-induced infiltration of neutrophils into the airways through nuclear factor-kappaB activation and IL-8 mRNA expression in guinea pigs in vivo. Am J Respir Cell Mol Biol 1999;20:189-98.
43. Reynaert NL, Ckless K, Korn SH, et al. Nitric oxide represses inhibitory kappaB kinase through S-nitrosylation. Proc Natl Acad Sci USA 2004;101:8945-50.
44. κB kinase. J Biol Chem 2001;276:35693-700.
45. Hirota K, Murata M, Sachi Y, et al. Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-kappaB. J Biol Chem 1999;274:27891-7.
46. Koul A, Bhatia V, Bansal MP. Effect of alpha-tocopherol on pulmonary antioxidant defence system and lipid peroxidation in cigarette smoke inhaling mice. BMC Biochemistry 2001;2:14.
47. Montuschi P, Collins JV, Ciabattoni G, et al. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med 2000;162:1175-7.